Search

everythinglearnresearchcommunity

for

Search:↓

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

Activating TRPV3 channels stops hair growth by killing hair follicle cells.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Developing microRNA-based treatments is hard but has potential.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

CaM7 and CNGC14 interaction controls root hair growth in Arabidopsis.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Lactobacillus acidophilus substances can kill and stop the spread of cervical cancer cells.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

EP 2 receptor is essential for heart repair by helping macrophages work properly.

Two compounds from Asiasarum heterotropoides roots show potential as lung cancer treatments without harming normal cells.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Multitarget drugs are needed to better treat complex diseases.